Figure 2From: Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779Examples of the three different subgroups of kidney cystadenomas in Tsc2+/- mice. All pictures were taken at a 20× magnification. a) Cystic lesions. b) Papillary lesions. c) Solid lesions.Back to article page